NetEase Inc vs BIO-TECHNE Corp — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: NetEase Inc is far larger — about 7.7× BIO-TECHNE Corp's market cap, and NetEase Inc pays the higher dividend (2.25%). Which is the better fit depends on your goals.
| NTES | TECH | |
|---|---|---|
Market Cap | $86.14B | $11.16B |
Sector | Media | Health |
52-Week High | $159.34 | $72.12 |
52-Week Low | $109.26 | $43.31 |
Enterprise Value | $62.61B | $11.24B |
Dividend Yield | 2.25% | 0.45% |
Trailing returns across standard periods
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →